Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
Atherosclerosis|September 24, 2022
Efficacy and safety of lomitapide in familial chylomicronaemia syndromeAngelo B Cefalù, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Circulation|August 19, 2009
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humansLaura Calabresi, Damiano Baldassarre, Samuela Castelnuovo, et al.
Journal of Hypertension|December 26, 2015
Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized studyPietro A Modesti, Stefano Omboni, Stefano Taddei, et al.
Atherosclerosis|July 1, 2026
Optimized flow cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemiaStella Covino, Alessia Di Costanzo, Alessandra Rossi, et al.
International Journal of Molecular Sciences|July 20, 2021
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL PathwaysVittoria Cammisotto, Francesco Baratta, Valentina Castellani, et al.
Giornale Italiano Di Cardiologia (2006)|December 27, 2022
[Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion]Claudio Bilato, Alberto Zambon, Livia Pisciotta, et al.
Atherosclerosis Plus|January 16, 2023
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
Atherosclerosis|December 29, 2016
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storageAlessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, et al.
JAMA|May 13, 2004
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and strokeFrancesco Cipollone, Elena Toniato, Stefano Martinotti, et al.
The Lancet Regional Health. Europe|April 24, 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
Atherosclerosis|September 24, 2022
Efficacy and safety of lomitapide in familial chylomicronaemia syndromeAngelo B Cefalù, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Circulation|August 19, 2009
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humansLaura Calabresi, Damiano Baldassarre, Samuela Castelnuovo, et al.
Journal of Hypertension|December 26, 2015
Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized studyPietro A Modesti, Stefano Omboni, Stefano Taddei, et al.
Atherosclerosis|July 1, 2026
Optimized flow cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemiaStella Covino, Alessia Di Costanzo, Alessandra Rossi, et al.
International Journal of Molecular Sciences|July 20, 2021
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL PathwaysVittoria Cammisotto, Francesco Baratta, Valentina Castellani, et al.
Giornale Italiano Di Cardiologia (2006)|December 27, 2022
[Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion]Claudio Bilato, Alberto Zambon, Livia Pisciotta, et al.
Atherosclerosis Plus|January 16, 2023
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
Atherosclerosis|December 29, 2016
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storageAlessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, et al.
JAMA|May 13, 2004
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and strokeFrancesco Cipollone, Elena Toniato, Stefano Martinotti, et al.
The Lancet Regional Health. Europe|April 24, 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
Pageof 22